You are here
IVF Research Study
The Center of Reproductive Medicine (CORM), in Webster, TX, is one of a number of fertility clinics across the country currently recruiting patients who have had repeated IVF failures despite having good-quality embryos for the THRIVE-IVF study. According to Vicki L. Schnell, M.D., FACOG, Founder & Medical Director of CORM, the study is evaluating a medicine, NT100, to determine whether it will improve the outcome of IVF. NT100 is similar to a naturally occurring protein in the female reproductive tract, and is being evaluated to determine if it improves a woman’s chances of getting pregnant following failed IVF cycles.
Her center, Schnell says, has participated in approximately 15 IVF studies and more than 1,000 patients have achieved pregnancy as a result. “It’s important we provide the newest therapy with highest success rates in a controlled fashion. We should be in a position to provide patients access to highly advanced technology and research to help them become pregnant.”
For more information on the study, contact The Center of Reproductive Medicine directly or view the THRIVE-IVF website.